Opthea Limited OPT
$ 3.16
0.96%
Annual report 2022
added 09-29-2022
Country |
Australia |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Megan Baldwin M.A.I.C.D., Ph.D., MAICD |
Employees in the company |
- |
Shares |
352 M |
Market Cap[1] |
$ 1.11 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.